NCT02635204View on ClinicalTrials.gov

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Psoriasis
Interventions
DRUG

DFD06 Cream

Twice daily topical application for 14 days.

DRUG

Vehicle Cream

Twice daily topical application for 14 days.

Trial Locations (30)

10019

Site 114, New York

23294

Site 125, Richmond

23507

Site 118, Norfolk

27804

Site 104, Rocky Mount

28401

Site 105, Wilmington

32204

Site 106, Jacksonville

33134

Site 112, Coral Gables

33406

130, West Palm Beach

33511

Site 108, Brandon

33781

Site 110, Pinellas Park

37215

Site 107, Nashville

45255

Site 126, Cincinnati

60005

Site 103, Arlington Heights

66215

Site 115, Overland Park

72758

Site 111, Rogers

75234

Site 101, Dallas

76014

128, Arlington

77056

Site 102, Houston

78229

Site 109, San Antonio

80220

Site 113, Denver

85308

Site 116, Glendale

89052

129, Henderson

92108

Site 122, San Diego

92123

Site 123, San Diego

92653

Site 120, Laguna Hills

92708

Site 124, Fountain Valley

06511

Site 117, New Haven

01915

Site 127, Beverly

02169

Site 119, Quincy

02886

Site 121, Warwick

All Listed Sponsors
lead

Promius Pharma, LLC

INDUSTRY

NCT02635204 - A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter